Your browser doesn't support javascript.
loading
Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial.
Stinchcombe, Thomas E.
Affiliation
  • Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA.
Transl Lung Cancer Res ; 12(7): 1655-1657, 2023 Jul 31.
Article in En | MEDLINE | ID: mdl-37577312
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2023 Document type: Article Affiliation country: United States Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2023 Document type: Article Affiliation country: United States Country of publication: China